Company Name: Global Blood Therapeutics Inc.
Global Blood Therapeutics Inc. is a clinical-stage biopharmaceutical company. The company is engaged in the development of therapeutics designed to treat blood-based disorders. The company’s lead product candidate is a therapy designed to treat sickle cell disease.
Ticker Symbol: GBT (NASDAQ)
Company Website: www.globalbloodtx.com
Social Media: Global Blood Therapeutics LinkedIn
Headquarters: South San Francisco, CA